September 17, 2025

Looking for Alzheimer’s

Retinal vascular dysfunction in common genetic mutation mirrors cerebrovascular disease, offering biomarker potential

The Ophthalmologist

September 16, 2025

New Genetic Understanding of RP59

Novel Dhdds mouse models illuminate pathogenesis of retinitis pigmentosa

The Ophthalmologist

September 10, 2025

Masters in the Making

How the Masters Video Library is reshaping ophthalmic education

The Ophthalmologist

September 08, 2025

Suppressing Pediatric Myopia

Omega-3 polyunsaturated fatty acids linked to lower myopia risk in children

The Ophthalmologist

September 05, 2025

Time Machine: Chapter 31

Some surgeons still pull cataracts out of the eye with a fish hook – but when did that start?

The Ophthalmologist

September 01, 2025

The Micron Wave

Although fitting by sagittal height is not new, awareness of this parameter has recently surged, and is increasingly discussed with other lens modalities, including rigid corneal lenses, orthokeratology lenses, and even modern soft lenses. In this article, the authors look at using the micron measurements when talking about height and fitting lenses.

Contact Lens Spectrum

September 01, 2025

Study Connects Iron Regulation and Vision Loss

PulseSight Therapeutics presented new research this week at the Euretina 2025 congress in Paris on the role of iron dysregulation in age-related macular degeneration (AMD), highlighting findings that support development of its investigational therapy PST-611 for dry AMD and geographic atrophy.

Retinal Physician

September 01, 2025

Migaldendranib Demonstrates Efficacy in DME and nAMD

At the Euretina Congress in Paris, Ashvattha Therapeutics reported that its investigational drug migaldendranib significantly reduced the need for intravitreal injections in patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) in a phase 2 trial. Data presented at Euretina showed reduced injection frequency as well as improvements in retinal structure and visual function.

Retinal Physician

September 01, 2025

Head-to-Head Trial Compares Iluvien and Anti-VEGF

Patients with diabetic macular edema who received the Iluvien implant needed less than half as many injections as those treated with aflibercept alone, according to data presented at Euretina 2025.

Retinal Physician